- 
                        Calluna Pharma Announces U.S. FDA Orphan Drug Designation Granted to CAL101 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
                        31 Oct 2025 12:49 GMT
                        
                           … has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for CAL101 …  President of Clinical Operations and Pharmacovigilance. “Our ongoing IPF study ( … enhanced efficacy and tolerability.
                          Calluna Pharma is incorporated in Oslo,  …
                         
- 
                        Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility
                        31 Oct 2025 15:00 GMT
                        
                           …  biologics, risk of drug interactions, generic drug competition, and regulatory … Inflammatory Drugs Market
                          In July 2025, Celebrex, a painkiller medicine  … May 2025, U.S FDA approval was received for  … mg dosages developed by Strides Pharma Global Pte. Limited,  …
                         
- 
                        Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript
                        31 Oct 2025 12:12 GMT
                        
                           … October 29, 2025
                          Vanda Pharmaceuticals Inc. misses on earnings … with the U.S. Food and Drug Administration for the resolution of … the interactions with the FDA proceed positively?
                          Mihael Polymeropoulos …  look like for these drugs?
                          Mihael Polymeropoulos: Yes. …
                         
- 
                        BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q3 2025 Earnings Call Transcript
                        31 Oct 2025 12:12 GMT
                        
                           …  October 29, 2025
                          BridgeBio Pharma, Inc. misses on earnings …  that can reliably produce medicines that matter with reasonable cadence … of dosing. Importantly, this drug brings differentiated promise to  …  on understanding how these drugs perform in the real …
                         
- 
                        Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
                        31 Oct 2025 11:42 GMT
                         …  from Viking’s obesity drug VK2735, fueling further optimism …  from Viking’s obesity drug VK2735, fueling further optimism …  with the U.S. Food and Drug Administration (FDA) by year-end to …  Investigational New Drug (IND) application with the FDA in the … 
- 
                        Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
                        31 Oct 2025 11:35 GMT
                         …  (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND),  … currently has no FDA-approved pharmacological treatment. The  … Medicine Inc. Clearmind is a clinical-stage psychedelic pharmaceutical … commercialize them as regulated medicines, foods or supplements … 
- 
                        Business News | USFDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
                        31 Oct 2025 11:16 GMT
                         …  31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to …  biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used … -name biologics, allowing patients and pharmacists to choose affordable options more … 
- 
                        The Trump administration move to study aluminum in vaccines worries scientists
                        31 Oct 2025 11:16 GMT
                         …  almost a century, some important vaccines, including shots that protect against …  who used to regulate vaccines at the Food and Drug Administration. "It basically stimulates …  deem aluminum unsafe as a vaccine ingredient, vaccine makers would have to … 
- 
                        Canadians can wait years to get drugs regulators have already deemed safe. Why?
                        31 Oct 2025 11:25 GMT
                        
                           …  more like rare-disease drugs. Pharmaceutical companies generally charge more … system for adding new drugs to public drug plans.
                          After Health … CEO of the pharmaceutical lobby group Innovative Medicines Canada, said the …  a drug is listed as soon as the FDA has  …
                         
- 
                        FDA recalls 581,000 blood pressure medication over cancer-causing chemicals
                        31 Oct 2025 10:27 GMT
                        
                          The United States Food and Drug Administration (FDA) has recalled a blood pressure  …  to treat high blood pressure.
                          FDA classified the medication as Class …  health consequences is remote.
                          Teva Pharmaceuticals issued a voluntary recall for …